Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
McVary
Kevin T
KT
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000368:Aged; D000369:Aged, 80 and over; D007172:Erectile Dysfunction / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010388:Pelvis / Q000503:physiopathology*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*; D001745:Urinary Bladder Diseases / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*
D010726:Phosphodiesterase Inhibitors; D015106:3',5'-Cyclic-GMP Phosphodiesterases